Have a personal or library account? Click to login
Consumption of Thyroid Medications as an Indicator of Increase of Thyroid Morbidity in Latvia from 2011 to 2014 Cover

Consumption of Thyroid Medications as an Indicator of Increase of Thyroid Morbidity in Latvia from 2011 to 2014

Open Access
|Jul 2019

References

  1. Anonymous (2012). 20. Vēstis [20th Proceedings]. The National Health Service of the Republic of Latvia (in Latvian). Available from: http://www.vmnvd.gov.lv/lv/publikacijas/vestis (accessed 15.05.2019).
  2. Anonymous (2014). Statistics On Medicines Consumption 2013. State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/default/files/inline-files/zva-zstat-2013.pdf (accessed 15.05.2019).
  3. Anonymous (2015). 23. Vēstis [23th Proceedings]. The National Health Service of the Republic of Latvia (in Latvian). Available from: http://www.vmnvd.gov.lv/lv/publikacijas/vestis (accessed 15.05.2019).
  4. Anonymous (2017). Guidelines for ATC classification and DDD assignment 2018. WHO Collaborating Centre for Drug Statistics Methodology. Available from: https://www.whocc.no/filearchive/publications/guidelines.pdf (accessed 15.05.2019).
  5. Anonymous (2018a). Kopsavilkums par cukura diabēta pacientiem, 2001.–2017. [Summary about patients with diabetes mellitus, 2001.–2017.]. The Centre for Disease Prevention and Control (CDPC) of Latvia (in Latvian). Available from: https://www.spkc.gov.lv/lv/statistika-un-petijumi/statistika/veselibas-aprupes-statistika1 (accessed 15.05.2019).
  6. Anonymous (2018b). Statistics On Medicines Consumption 2017. State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/deault/files/inline-files/zva-zstat-2013.pdf (accessed 15.05.2019).
  7. Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T., Vanderpump, M. (2018). 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dys-function. Eur. Thyroid J., 7 (2), 55–66.10.1159/000486957
  8. Carter, Y., Sippel, R. S., Chen, H. (2013). Hypothyroidism after a cancer diagnosis: Etiology, diagnosis, complications, and management. The Oncologist, 19 (1), 34–43.10.1634/theoncologist.2013-0237
  9. Hollowel, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., Braverman, L. E. (2002). Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab., 87 (2), 489–499.10.1210/jcem.87.2.8182
  10. Kahaly, G. J., Dietlein, M. (2002). Cost estimation of thyroid disorders in Germany. Thyroid, 12 (10), 909–914.10.1089/105072502761016548
  11. Koutras, D. A. (1997). Disturbances of menstruation in thyroid disease. Ann. New York Acad. Sci., 816 (1), 280–284.10.1111/j.1749-6632.1997.tb52152.x
  12. Leo, S. D., Lee, S. Y., Braverman, L. E. (2016). Hyperthyroidism. The Lancet, 388 (10047), 906–918.10.1016/S0140-6736(16)00278-6
  13. Madariaga, A. G., Palacios, S. S., Guillén-Grima, F., Galofré, J. C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J. Clin. Endocrinol. Metab., 99 (3), 923–931.10.1210/jc.2013-2409
  14. Møllehave, L., Linneberg, A., Skaaby, T., Knudsen, N., Ehlers, L., Jørgensen, T., Thuesen, B. (2018). Trends in costs of thyroid disease treatment in Denmark during 1995–2015. Eur. Thyroid J.,7 (2), 75–83.10.1159/000485973
  15. Pearce, S. H., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., Wemeau, J. (2013). 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur. Thyroid J., 2 (4), 215–22810.1159/000356507
  16. Pirich, C., Müllner, M., Sinzinger, H. (2000). Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J. Clin. Epidemiol., 53 (6), 623–629.10.1016/S0895-4356(99)00187-0
  17. Rhee, C. M., Bhan, I., Alexander, E. K., Brunelli, S. M. (2012). Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch. Int. Med., 172 (2), 153.10.1001/archinternmed.2011.67722271121
  18. Rootslane L., Laius O., Sepp J., Kurvits K., Seilis A., Gailīte E., Ķikute D., Dr Gulbinovič J., Tomaševič R., Stasevičiūtė V. (2013). Baltic Statistics On Medicine 2010–2012. Estonian State Agency Of Medicines. Available from: http://www.ravimiamet.ee/sites/default/files/documents/publications/baltic_statistics_on_medicines_2010_2012/files/mobile/index.html#4 (accessed 15.05.2019).
  19. Seilis A., Gailīte E., Rootslane L., Laius O., Savaikis L., Tomaševič R. (2016). Baltic Statistics On Medicine 2013–2015. Estonian State Agency Of Medicines. Available from: https://www.zva.gov.lv/sites/default/files/2017-12/Baltic%20Statistics%20on%20Medicines%202013%20-%202015.pdf (accessed 15.05.2019).
  20. Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature Rev. Endocrinol.,14 (5), 301–316.10.1038/nrendo.2018.1829569622
  21. Vanderpump, M. P. (2011). The epidemiology of thyroid disease. Brit. Med. Bull.,99 (1), 39–51.10.1093/bmb/ldr03021893493
DOI: https://doi.org/10.2478/prolas-2019-0064 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 407 - 410
Submitted on: Jan 3, 2019
|
Accepted on: May 24, 2019
|
Published on: Jul 12, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2019 Ieva Kalere, Ieva Strēle, Mārtiņš Miglinieks, Ilze Repša, Santa Pildava, Mihails Romanovs, Valdis Pīrāgs, Ilze Konrāde, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.